Navigation Links
Researchers find promising cancer-fighting power of synthetic cell-signaling molecule

Liotta and his colleagues at Emory prepared almost 100 sphingolipid-based analogs that lead to the discovery that the Enigmols were the most potent. The lead compounds were named "Enigmols" because sphingolipids were named after the sphinx for their enigmatic properties. Emory University holds the patent on compounds of this type.

In addition to being more potent than naturally occurring sphingolipids, the researchers have also found that Enigmols can be administered orally and appear in often-difficult-to reach organs such as the prostate. "This is what suggested to us that Enigmols should be tested against other cancer types," Merrill explained.

Subsequently, the researchers found that Enigmols suppress the growth of human prostate tumors implanted in mice, which is a commonly used model to test new anti-cancer drugs. They were also effective in two other mouse models for colon cancer.

"We do not know why Enigmols affect such a wide range of tumor cell types," Merrill said. "But it may be due to the involvement of sphingolipids in multiple cell-signaling pathways. This means a compound may affect several different targets, rather than just one."

In essence, Enigmols may act like a multi-drug combination therapy, the investigators speculate.

Enigmols are also being tested in combination with other cancer chemotherapeutic drugs using funds from EmTech Bio -- a life sciences technology business incubator operated by Georgia Tech and Emory. This research is coordinated with Slainte Bioceuticals, a start-up biotechnology company in metro Atlanta that is helping to bring this potential drug to market.

"Even if Enigmols are effective in humans, the greatest success is likely to come from the right combination of drugs that interact in a synergistic way," Merrill noted. So information from the EmTech Bio study may be particularly useful if Enigmols enter human clinical trials because the patients will have undergone, and wil
'"/>

Source:Georgia Institute of Technology Research News


Page: 1 2 3

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
(Date:5/24/2013)... and other non-coding RNAs are small molecules that ... recent years they have emerged as disease biomarkers. ... origin for cancers of unknown primary origin, determine ... but clinically tractable, diagnostic methods for monitoring miRNA ... In this issue of the Journal of ...
(Date:5/23/2013)... to be the world,s most popular fruit, can be ... with purple GM varieties. , "Working with GM ... the addition of a specific compound, allows us to ... Professor Cathie Martin from the John Innes Centre. , ... better flavour, health and shelf life characteristics because even ...
(Date:5/23/2013)... of genomic DNA around nucleosomes in the cell ... team of Ludwig-Maximilians-Universitaet (LMU) in Munich now describes ... locally displaced from nucleosomes for transcription. , In ... the cell nucleus, wrapped around disk-shaped particles called ... different histone proteins and accommodating two loops of ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Biochemistry: Unspooling DNA from nucleosomal disks 2
... Des Moines, Iowa March 1, 2010 You ... three language-competent bonobos living at Great Ape Trust, than you ... day tell scientists more about the effect of culture on ... is a universal language, an alternative to spoken words to ...
... years on Down,s syndrome has focused on the DYRK1A ... the neurones, according to Mr Garikoitz Azkona. In his ... Down,s syndrome: the role of DYRK1A , Mr Azkona ... behind the problem that persons with Down,s syndrome have ...
... well known for keeping us healthy as it is for ... new research report appearing in the March 2010 print issue ... explain how they developed a genetically modified strain of tobacco ... scientifically known as microcystin-LR (MC-LR), which makes water unsafe for ...
Cached Biology News:If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 2If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 3DYRK1A gene may be 1 of most influential factors in Down syndrome 2
(Date:5/24/2013)... -- Senomyx , Inc. (NASDAQ: SNMX ... discover, develop, and commercialize novel flavor ingredients, announced today ... Company,s Vice President, Biology and Gwen Rosenberg ... will present an overview of Senomyx,s technology and programs ... (7:25 a.m. Pacific Time) during the Citi 2013 Global ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)... , May 24, 2013 Die ... – Bei der englischen Version ... , 91 % der Teilnehmer einer groß angelegten Asthmaumfrage ... % laut GINA [*] -Definition [1] als kontrolliert ... mit Asthma generell einer von vier Denkweisen zugeordnet werden ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7
... and Products Offset Patent Expirations, SAN FRANCISCO, ... of major neuropathic pain (NP) conditions is currently ... a report released today by,WWMR, Inc. Growth over ... by the,successful launch of Lyrica (pregabalin) for diabetic ...
... in Pharmaceutical Thin Film,Technology -, WARREN, N.J., ... specializing in quick dissolving thin film pharmaceutical products,today ... No. 7,425,292 from the,United States Patent and Trademark ... to issue on September 16, 2008, relates,to the ...
... 11 BioTrends Research Group, Inc. is,pleased to announce ... report in a series conducted with Anemia Managers. It ... by 150 Anemia Managers,-- 100 working with dialysis patients ... patients, and qualitative interviews with a,subset of 25 respondents. ...
Cached Biology Technology:US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 2US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 3MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 3New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 2New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 3
... SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit ... Catalog #9251, 200 ul SAPK/JNK (56G8) ... SAPK/JNK Cell Extracts, Catalog #9253, (4 ... Catalog #7074, 100 ul Anti-biotin IgG, ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: